AJP - Heart Ad Instruments
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol (November 21, 2008). doi:10.1152/ajpheart.01056.2008
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
296/1/H13    most recent
01056.2008v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Laczy, B.
Right arrow Articles by Chatham, J. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Laczy, B.
Right arrow Articles by Chatham, J. C.
Submitted on October 2, 2008
Revised on October 23, 2008
Accepted on November 11, 2008

Protein O-GlcNAcylation: A new signaling paradigm for the cardiovascular system

Boglarka Laczy1, Bradford G. Hill1, Kai Wang1, Andrew J Paterson1, C. Roger White1, Dongqi Xing2, Yiu-Fai Chen3, Victor Darley-Usmar1, Suzanne Oparil1, and John C. Chatham1*

1 University of Alabama at Birmingham
2 UAB
3 1008 Zeigler Research Building

* To whom correspondence should be addressed. E-mail: jchatham{at}uab.edu.

The post translation modification of serine or threonine residues of nuclear and cytoplasmic proteins by the O-linked attachment of the monosaccharide {beta}-N-acetyl-glucosamine (O-GlcNAc) is a highly dynamic and ubiquitous protein modification. Protein O-GlcNAcylation is rapidly emerging as a key regulator of critical biological processes including nuclear transport, translation and transcription, signal transduction, cytoskeletal reorganization, proteasomal degradation and apoptosis. Increased levels of O-GlcNAc have been implicated as a pathogenic contributor to glucose toxicity and insulin resistance major hallmarks of diabetes mellitus and diabetes-related cardio vascular complications. Conversely, there is a growing body of data demonstrating that the acute activation of O-GlcNAc levels is an endogenous stress response designed to enhance cell survival. Reports on the effect of altered O-GlcNAc levels on the heart and cardiovascular system have been growing rapidly over the past few years and have implicated a role for O-GlcNAc in contributing to the adverse effects of diabetes on cardiovascular function as well as mediating the response to ischemic injury. Here we summarize our current understanding of protein O-GlcNAcylation and its effect on the regulation of cardiovascular function. We examine the pathways regulating protein O-GlcNAcylation and discuss in more detail our current understanding of the role of O-GlcNAc in mediating both adverse effects of diabetes as well as its role in mediating cellular protective mechanisms in the cardiovascular system. In addition we also explore the parallels between O-GlcNAc signaling and redox signaling as an alternative paradigm for understanding the role of O-GlcNAcylation in regulating cell function.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 1977 by the American Physiological Society.